Page last updated: 2024-10-25

eflornithine and Brain Stem Neoplasms

eflornithine has been researched along with Brain Stem Neoplasms in 1 studies

Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.

Brain Stem Neoplasms: Benign and malignant intra-axial tumors of the MESENCEPHALON; PONS; or MEDULLA OBLONGATA of the BRAIN STEM. Primary and metastatic neoplasms may occur in this location. Clinical features include ATAXIA, cranial neuropathies (see CRANIAL NERVE DISEASES), NAUSEA, hemiparesis (see HEMIPLEGIA), and quadriparesis. Primary brain stem neoplasms are more frequent in children. Histologic subtypes include GLIOMA; HEMANGIOBLASTOMA; GANGLIOGLIOMA; and EPENDYMOMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Khan, A1
Gamble, LD1
Upton, DH1
Ung, C1
Yu, DMT1
Ehteda, A1
Pandher, R1
Mayoh, C1
Hébert, S1
Jabado, N1
Kleinman, CL1
Burns, MR1
Norris, MD1
Haber, M1
Tsoli, M1
Ziegler, DS1

Other Studies

1 other study available for eflornithine and Brain Stem Neoplasms

ArticleYear
Dual targeting of polyamine synthesis and uptake in diffuse intrinsic pontine gliomas.
    Nature communications, 2021, 02-12, Volume: 12, Issue:1

    Topics: Animals; Biological Transport; Brain Stem Neoplasms; Cell Death; Cell Line, Tumor; Cell Proliferatio

2021